Where is Enliven Therapeutics headquarters?
Enliven Therapeutics maintains its corporate headquarters in Burlingame, California, having relocated its primary executive operations to the dynamic San Francisco Bay Area biotechnology hub. This strategic location places the precision oncology company close to major life science clusters, venture capital networks, and premier academic research institutions. The headquarters oversees corporate governance, clinical development strategies, and specialized drug discovery pipelines aimed at creating breakthrough therapies for cancer patients.
Related FAQs
Enliven Therapeutics, Inc. officially completed its initial public offering on March 12, 2020, pricing its shares on the NASDAQ stock exchange under the ticker symbol ELVN.
In a corporate, organizational, or wellness context, an enterprise named Enliven typically focuses on breathing vitality, energy, and engagement into workplaces, communities, or health programs.
Amylin Pharmaceuticals historically traded on the NASDAQ global select market under the ticker symbol AMLN prior to its acquisition by Bristol-Myers Squibb.
Maplight Therapeutics, Inc.
The antonym most commonly used to express the exact opposite of enliven is deaden, while words like dampen, depress, weary, dull, exhaust, or stifle also capture the semantic reversal of the term.
Yes, Enliven Therapeutics is a public company. Based in Boulder, United States, it operates as a biopharmaceutical developer focused on creating precision therapies for solid tumors and blood cancers.
Emaar Properties PJSC commands a massive corporate market capitalization of approximately 107.12 billion UAE dirhams (or roughly ₹2.57 trillion).
ELVN is not a generic acronym; rather, it is the ticker symbol for Enliven Therapeutics.
In standard English vocabulary, the verb "enliven" means to make something more entertaining, cheerful, spirited, or active, bringing life, energy, or animation to a situation, conversation, or environment.
Determining whether a specific corporate entity, such as an enterprise registered under the name Eternal Limited, is experiencing business growth requires a detailed examination of its most recent financial statements, annual reports, revenue streams...
Evaluating companies bearing the name Luna requires verifying the specific ticker symbol and underlying enterprise—such as technology, aerospace, or consumer goods firms—before making investment choices.
Amylin Pharmaceuticals, a pioneering biopharmaceutical company renowned for developing breakthrough treatments for diabetes such as exenatide and pramlintide, was acquired by the global healthcare giant Bristol-Myers Squibb in a multi-billion-dollar ...
Enliven Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to discovering and developing next-generation small molecule therapies to overcome resistance in cancer treatment.
Enliven Therapeutics is located in Burlingame, California, where its corporate headquarters and primary leadership teams are situated.
The public offering price of an initial public offering (IPO) is the final dollar value assigned to each share of stock sold by a company to investors when it transitions from private ownership to public exchange trading.
There is no single stock titled "Elon Musk stock," but investors who wish to gain exposure to the companies led by Elon Musk typically invest in Tesla, Inc. (TSLA), which is the most significant public equity he controls.
The term "eliven" is an uncommon variant or archaic form related to words meaning to enliven, invigorate, or bring a sense of life and animation to something or someone.
"Lona" is not a widely recognized primary ticker symbol on major global stock exchanges like the NYSE, NASDAQ, or LSE.